Live Breaking News & Updates on New england journal

Stay informed with the latest breaking news from New england journal on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in New england journal and stay connected to the pulse of your community

Do cutting-edge CAR-T-cell therapies cause cancer? What the data say

Regulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is CAR T to blame? The hunt is on for answers. Regulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is CAR T to blame? The hunt is on for answers.

Australia , United-states , Philadelphia , Pennsylvania , London , City-of , United-kingdom , University-of-pennsylvania , Stanford-university , California , Washington , Arizona

Lung Cancer Research Foundation Welcomes New Scientific Advisory Board Members

/PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) has expanded its Scientific Advisory Board (SAB) by five new members. Led by Katerina Politi, PhD,...

Michigan , United-states , California , Spain , Germany , Dana-farber-cancer-institute , Massachusetts , Italy , Heidelberg , Baden-wüberg , Madrid , American

Lixisenatide Decreases Motor Disability Progression in Early Parkinson Disease

Among patients with PD, lixisenatide is associated with a decrease in motor disability progression and has gastrointestinal side effects.

France , Movement-disorder-society , New-england-journal , Unified-parkinson , Disease-rating-scale ,

Eli Lilly's growth drivers, Verzenio and Jardiance, suffer clinical setbacks

Eli Lilly's growth drivers, Verzenio and Jardiance, suffer clinical setbacks
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Novarti-kisqali , Eli-lilly , Astrazeneca , Novartis , Johnson , Boehringer-ingelheim-partnered , New-england-journal , Inflation-reduction-act , Wall-street ,

Encore: The Doctor is No Longer In: Conversations with physicians about why they are quitting

According to data released more than two years ago, the American Medical Association is warning that about 1 in 5 U.S. physicians are leaving, or scaling back patient care. Our guest is one of those 1 in 5 doctors the AMA warned would quit practicing. Dr. Maryann Wilbur is now a non-practicing surgeon. She’s a GYN Oncologist — that means she’s a surgeon who focuses on cancers of the female reproductive tract. She is now Director & CEO of a new startup called Health Equity Consulting; and co-author of a book called \“The Doctor is No Longer In: Conversations with U.S. physicians\” which will compile data collected from interviews with physicians who have recently left practice.

Florida , United-states , American , Maryann-wilbur , Katherine-rieth , Boston-university-school-of-medicine , Health-equity-consulting , University-of-rochester-school-medicine , American-medical-association , Boston-university-school , Johns-hopkins-hospital , New-england-journal

'Landmark' Findings Led to Alecensa Approval for ALK-Positive NSCLC

Alecensa was shown to reduce the risk of disease recurrence or death by 76% versus chemotherapy for patients with ALK-positive non-small cell lung cancer.

Upal-basu-roy , Drug-administration , Lungevity-foundation , New-england-journal , Nsclc , Lung-cancer-treatment , Alecensa , Non-small-cell-lung-cancer ,

These 10 Weight Loss Drugs Like Ozempic Can Work, but Are They Safe?

These 10 Weight Loss Drugs Like Ozempic Can Work, but Are They Safe?
discovermagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from discovermagazine.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Setmelanotide-imcivree , Kzenon-shutterstock , Steve-george , Dapagliflozin-farxiga , Topiramate-qysmia , Tirzepatide-zepbound , Liraglutide-saxenda , Semaglutide-ozempic , Men-health , Centers-for-disease

What you need to know about 'game changer' food allergy drug

The drug omalizumab, commonly used to treat asthma, nasal polyps, and hives, prevents severe reactions in people with food allergies.

Emily-weis , Katherine-tuttle , University-of-rochester-medical-center , New-england-journal , Golisano-children , Strong-memorial-hospital , Rochester-medical-center ,

Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript

Sanofi reports earnings inline with expectations. Reported EPS is $0.96 EPS, expectations were $0.96.

Australia , San-diego , California , United-states , Germany , Japan , France , Spain , China , Chile , Australian , Peter-welford

Exagamglogene Autotemcel Shows Promise in Treatment of Transfusion-Dependent β-Thalassemia

An ongoing, phase 3, open-label study demonstrated the efficacy of exagamglogene autotemcel (exa-cel) infusion to promote transfusion dependence in patients with transfusion-dependent β-thalassemia (TDT).

United-kingdom , Italy , Canada , Germany , New-england-journal , Receiving-blood-transfusion , Blood-transfusion , Cell-therapy , Beta-thalassemia , Anemia ,